Press "esc" to clear
Go to Advanced Search

Showing results

110 of 85
  • Embargo expired:
    20-Sep-2018 11:00 AM EDT

Article ID: 700567

Novel Biomarker Found in Ovarian Cancer Patients Can Predict Response to Therapy

University of Chicago Medical Center

Researchers have identified an independent prognostic factor, cancer/testis antigen 45, that is associated with extended disease-free survival for women with advanced ovarian cancer. Patients with high levels of CT45 in their tumors lived more than seven times as long as patients who lacked sufficient CT45.

14-Sep-2018 12:05 PM EDT
  • Embargo expired:
    23-Aug-2018 11:00 AM EDT

Article ID: 699398

Integrated Analysis Finds Vulnerabilities to Target in a High-Risk Pediatric Tumor

St. Jude Children's Research Hospital

Research from the St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project has revealed new vulnerabilities and leads for treatment of rhabdomyosarcoma

22-Aug-2018 4:05 PM EDT

Article ID: 699162

Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

University of Colorado Cancer Center

Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.

17-Aug-2018 12:15 PM EDT
  • Embargo expired:
    1-Aug-2018 9:00 AM EDT

Article ID: 697944

Financial Checkup Should Be Part of Health Screenings for Childhood Cancer Survivors

St. Jude Children's Research Hospital

Adult survivors of childhood cancer should be screened for financial problems that might cause them to delay or skip medical care or to suffer psychological distress. The recommendation from St. Jude Children’s Research Hospital researchers followed an analysis that found 65 percent of survivors reported financial challenges related to their childhood cancer diagnoses. More than half of survivors (51.1 percent) indicated they worried about paying for care, and 33 percent said finances kept them from seeking medical care.

25-Jul-2018 10:35 AM EDT

Article ID: 697182

Crystal Structure Reveals How Curcumin Impairs Cancer

University of California San Diego Health

Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and Zhejiang University, reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 (DYRK2) at the atomic level. This previously unreported biochemical interaction of curcumin leads to inhibition of DYRK2 that impairs cell proliferation and reduces cancer burden.

9-Jul-2018 3:35 PM EDT

Article ID: 696485

Light-Based, 15-Second Scan Aims to Replace Painful Mammograms

National Institute of Biomedical Imaging and Bioengineering

Up to 50% of women skip potentially life-saving mammograms often because they can cause extreme discomfort. Now researchers have developed a painless, light-based, non-radioactive, 15-second procedure that could revolutionize breast cancer screening and save lives.

21-Jun-2018 2:05 PM EDT

Article ID: 694701

Improving Survival in Pancreatic Cancer with Platinum-Based Chemotherapy

Johns Hopkins Medicine

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

17-May-2018 8:00 AM EDT
  • Embargo expired:
    10-May-2018 4:00 PM EDT

Article ID: 693844

Study Reveals That Many Oncologists Recommend Medical Marijuana Clinically Despite Not Feeling Sufficiently Knowledgeable to Do So

Dana-Farber Cancer Institute

While a wide majority of oncologists do not feel informed enough about medical marijuana’s utility to make clinical recommendations, most do in fact conduct discussions on medical marijuana in the clinic and nearly half recommend it to their patients, say researchers who surveyed a population-based sample of medical oncologists.

1-May-2018 5:00 PM EDT

Article ID: 692455

New Drug Combo Improves Survival of Women with Rare Uterine Cancer

Johns Hopkins Medicine

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.

10-Apr-2018 10:00 AM EDT
  • Embargo expired:
    14-Mar-2018 4:30 PM EDT

Article ID: 691041

Targeting a Signaling Pathway with a Diabetes Drug may be a Potential Strategy in Treating, Preventing Pancreatic Cancer Progression

Rutgers Cancer Institute of New Jersey

Research by Rutgers Cancer Institute of New Jersey investigators explores the use of a diabetes drug and its impact on pancreatic cancer and finds that targeting a certain signaling pathway with this agent may be a novel strategy for the prevention and treatment of metastatic pancreatic cancer.

13-Mar-2018 2:40 PM EDT

Showing results

110 of 85

Chat now!